

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | iron ion import (GO:0097286) | 4.88611819 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67392542 |
| 3 | modulation by symbiont of host defense response (GO:0052031) | 4.52078142 |
| 4 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.52078142 |
| 5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.52078142 |
| 6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.52078142 |
| 7 | modulation by symbiont of host immune response (GO:0052553) | 4.52078142 |
| 8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.52078142 |
| 9 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.88935843 |
| 10 | positive regulation of muscle hypertrophy (GO:0014742) | 3.76031404 |
| 11 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.76031404 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 3.75536213 |
| 13 | ganglion development (GO:0061548) | 3.69733250 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69241527 |
| 15 | definitive hemopoiesis (GO:0060216) | 3.61910339 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 3.60709714 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.58415729 |
| 18 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.48530256 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.44249067 |
| 20 | COPI coating of Golgi vesicle (GO:0048205) | 3.40313748 |
| 21 | Golgi transport vesicle coating (GO:0048200) | 3.40313748 |
| 22 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.38848760 |
| 23 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.32624943 |
| 24 | sequestering of metal ion (GO:0051238) | 3.28770293 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.24914673 |
| 26 | cellular response to ethanol (GO:0071361) | 3.24669253 |
| 27 | establishment of protein localization to Golgi (GO:0072600) | 3.22698337 |
| 28 | ER overload response (GO:0006983) | 3.19365177 |
| 29 | protein targeting to Golgi (GO:0000042) | 3.18469823 |
| 30 | melanin biosynthetic process (GO:0042438) | 3.13791121 |
| 31 | microglial cell activation (GO:0001774) | 3.11659558 |
| 32 | histone H3-K4 trimethylation (GO:0080182) | 3.07287742 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.07250699 |
| 34 | response to host immune response (GO:0052572) | 3.07250699 |
| 35 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.06739092 |
| 36 | regulation of somitogenesis (GO:0014807) | 3.05911490 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.04405460 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.00981056 |
| 39 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.99867128 |
| 40 | erythrocyte development (GO:0048821) | 2.98277365 |
| 41 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.96951705 |
| 42 | Golgi to endosome transport (GO:0006895) | 2.95032862 |
| 43 | histamine secretion (GO:0001821) | 2.94443998 |
| 44 | nuclear pore organization (GO:0006999) | 2.92401563 |
| 45 | detection of external biotic stimulus (GO:0098581) | 2.92344531 |
| 46 | positive regulation of granulocyte differentiation (GO:0030854) | 2.91558494 |
| 47 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.91233838 |
| 48 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.90842424 |
| 49 | response to peptidoglycan (GO:0032494) | 2.88738295 |
| 50 | regulation of mononuclear cell migration (GO:0071675) | 2.85132329 |
| 51 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83782584 |
| 52 | response to host (GO:0075136) | 2.83782584 |
| 53 | response to host defenses (GO:0052200) | 2.83782584 |
| 54 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.80885081 |
| 55 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.79603055 |
| 56 | embryonic hemopoiesis (GO:0035162) | 2.78848301 |
| 57 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.77827862 |
| 58 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.77259874 |
| 59 | developmental pigmentation (GO:0048066) | 2.75101304 |
| 60 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.75043583 |
| 61 | myeloid cell development (GO:0061515) | 2.74399127 |
| 62 | neutrophil activation (GO:0042119) | 2.73498306 |
| 63 | positive regulation of interferon-beta production (GO:0032728) | 2.72893742 |
| 64 | type B pancreatic cell development (GO:0003323) | 2.72399158 |
| 65 | cellular response to arsenic-containing substance (GO:0071243) | 2.71919809 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70946686 |
| 67 | I-kappaB phosphorylation (GO:0007252) | 2.70653538 |
| 68 | histone mRNA catabolic process (GO:0071044) | 2.69945628 |
| 69 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.69730050 |
| 70 | neutrophil mediated immunity (GO:0002446) | 2.69159934 |
| 71 | regulation of muscle hypertrophy (GO:0014743) | 2.68943795 |
| 72 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68816921 |
| 73 | melanin metabolic process (GO:0006582) | 2.68779260 |
| 74 | B cell receptor signaling pathway (GO:0050853) | 2.68078388 |
| 75 | response to lipoprotein particle (GO:0055094) | 2.67187995 |
| 76 | granulocyte activation (GO:0036230) | 2.66283536 |
| 77 | erythrocyte maturation (GO:0043249) | 2.65206990 |
| 78 | myeloid leukocyte mediated immunity (GO:0002444) | 2.64310639 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.64227630 |
| 80 | exocrine pancreas development (GO:0031017) | 2.63569153 |
| 81 | prostate gland growth (GO:0060736) | 2.58301150 |
| 82 | macrophage activation (GO:0042116) | 2.58148096 |
| 83 | neural tube formation (GO:0001841) | 2.57221094 |
| 84 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.56417319 |
| 85 | regulation of sarcomere organization (GO:0060297) | 2.56318497 |
| 86 | eosinophil chemotaxis (GO:0048245) | 2.55783892 |
| 87 | axon extension involved in axon guidance (GO:0048846) | 2.55531614 |
| 88 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.55531614 |
| 89 | histamine transport (GO:0051608) | 2.54356350 |
| 90 | T cell mediated immunity (GO:0002456) | 2.50724788 |
| 91 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.50207172 |
| 92 | response to interleukin-15 (GO:0070672) | 2.49868163 |
| 93 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.49019840 |
| 94 | negative regulation of mast cell activation (GO:0033004) | 2.47432773 |
| 95 | detection of other organism (GO:0098543) | 2.47162730 |
| 96 | cell adhesion mediated by integrin (GO:0033627) | 2.46623079 |
| 97 | * cellular copper ion homeostasis (GO:0006878) | 2.46092358 |
| 98 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.46077424 |
| 99 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.46077424 |
| 100 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.45410110 |
| 101 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.45333611 |
| 102 | T-helper 1 type immune response (GO:0042088) | 2.44266364 |
| 103 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.44193468 |
| 104 | germinal center formation (GO:0002467) | 2.44104898 |
| 105 | detection of biotic stimulus (GO:0009595) | 2.43437570 |
| 106 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.42846460 |
| 107 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.41049155 |
| 108 | N-terminal protein amino acid acetylation (GO:0006474) | 2.41040233 |
| 109 | regulation of mast cell degranulation (GO:0043304) | 2.40773609 |
| 110 | histone lysine demethylation (GO:0070076) | 2.40582016 |
| 111 | nuclear pore complex assembly (GO:0051292) | 2.40260197 |
| 112 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39124266 |
| 113 | dorsal/ventral axis specification (GO:0009950) | 2.38221257 |
| 114 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.37925665 |
| 115 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.37850713 |
| 116 | secondary metabolite biosynthetic process (GO:0044550) | 2.36173764 |
| 117 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.35352150 |
| 118 | histone demethylation (GO:0016577) | 2.34787175 |
| 119 | establishment of skin barrier (GO:0061436) | 2.34754011 |
| 120 | histone H3-K36 demethylation (GO:0070544) | 2.34592552 |
| 121 | nerve growth factor signaling pathway (GO:0038180) | 2.34483592 |
| 122 | wound healing, spreading of epidermal cells (GO:0035313) | 2.33848753 |
| 123 | macroautophagy (GO:0016236) | 2.33733188 |
| 124 | negative regulation of bone resorption (GO:0045779) | 2.33420680 |
| 125 | hypotonic response (GO:0006971) | 2.32522886 |
| 126 | replicative senescence (GO:0090399) | 2.31851666 |
| 127 | detection of molecule of bacterial origin (GO:0032490) | 2.31461330 |
| 128 | protein targeting to lysosome (GO:0006622) | 2.31457945 |
| 129 | establishment of protein localization to vacuole (GO:0072666) | 2.31457945 |
| 130 | protein targeting to vacuole (GO:0006623) | 2.31457945 |
| 131 | oxygen transport (GO:0015671) | 2.31284715 |
| 132 | positive regulation of cell size (GO:0045793) | 2.30594046 |
| 133 | interkinetic nuclear migration (GO:0022027) | 2.30401220 |
| 134 | regulation of gamma-delta T cell activation (GO:0046643) | 2.30185858 |
| 135 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.30071419 |
| 136 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.29915245 |
| 137 | regulation of RNA export from nucleus (GO:0046831) | 2.29894334 |
| 138 | blood vessel maturation (GO:0001955) | 2.28997981 |
| 139 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.28756088 |
| 140 | peptidyl-lysine trimethylation (GO:0018023) | 2.28308617 |
| 141 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.27580501 |
| 142 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.27580501 |
| 143 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.27580501 |
| 144 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.27538536 |
| 145 | positive regulation of digestive system process (GO:0060456) | 2.27447651 |
| 146 | lipid translocation (GO:0034204) | 2.25964506 |
| 147 | phospholipid translocation (GO:0045332) | 2.25964506 |
| 148 | response to muramyl dipeptide (GO:0032495) | 2.25566058 |
| 149 | cellular response to ATP (GO:0071318) | 2.24468587 |
| 150 | pore complex assembly (GO:0046931) | 2.24235015 |
| 151 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.23728019 |
| 152 | cellular response to vitamin D (GO:0071305) | 2.23527513 |
| 153 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.23234463 |
| 154 | positive regulation of macrophage cytokine production (GO:0060907) | 2.22738479 |
| 155 | cellular extravasation (GO:0045123) | 2.18484574 |
| 156 | fibroblast migration (GO:0010761) | 2.18461090 |
| 157 | substrate-dependent cell migration (GO:0006929) | 2.17830463 |
| 158 | phagocytosis, engulfment (GO:0006911) | 2.16841558 |
| 159 | positive regulation of chemokine production (GO:0032722) | 2.15909327 |
| 160 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.15623828 |
| 161 | glandular epithelial cell development (GO:0002068) | 2.15206364 |
| 162 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.15205410 |
| 163 | natural killer cell mediated immunity (GO:0002228) | 2.15205410 |
| 164 | eosinophil migration (GO:0072677) | 2.14935422 |
| 165 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.14247335 |
| 166 | phenol-containing compound catabolic process (GO:0019336) | 2.13060045 |
| 167 | positive regulation of actin filament depolymerization (GO:0030836) | 2.12879358 |
| 168 | regulation of mast cell activation (GO:0033003) | 2.12813549 |
| 169 | positive regulation of interleukin-12 production (GO:0032735) | 2.11682302 |
| 170 | positive regulation of antigen processing and presentation (GO:0002579) | 2.09709912 |
| 171 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.08632967 |
| 172 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.07106864 |
| 173 | dendritic cell migration (GO:0036336) | 2.06100786 |
| 174 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.05655794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.32437514 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.56877618 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80206301 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61172869 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41097208 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95306256 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.90049153 |
| 8 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.85734302 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73091468 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71987758 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63196249 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.41903802 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41749492 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.33168333 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23187740 |
| 16 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.13067415 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04090578 |
| 18 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.03508388 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.97956094 |
| 20 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.95516435 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93884613 |
| 22 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.91045051 |
| 23 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.84865794 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82844088 |
| 25 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.81542277 |
| 26 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.81358238 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.79786909 |
| 28 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.79133627 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78123103 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.76736389 |
| 31 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73525353 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.72830402 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67957261 |
| 34 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.67660728 |
| 35 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65616712 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.65486316 |
| 37 | GATA1_19941826_ChIP-Seq_K562_Human | 1.65329045 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.64176224 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.63346280 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.61352625 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.60480578 |
| 42 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55509454 |
| 43 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55443895 |
| 44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53311557 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50593451 |
| 46 | GATA2_19941826_ChIP-Seq_K562_Human | 1.48836052 |
| 47 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46039782 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44248516 |
| 49 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44248516 |
| 50 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42862722 |
| 51 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.42853993 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42328154 |
| 53 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.42140617 |
| 54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.41424116 |
| 55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.41424116 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.40217934 |
| 57 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.37611611 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.35709921 |
| 59 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35292309 |
| 60 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34885679 |
| 61 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34380738 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32245088 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31314492 |
| 64 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30928911 |
| 65 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.30736316 |
| 66 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.30476151 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29932278 |
| 68 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28375525 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26604566 |
| 70 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25965702 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.24840655 |
| 72 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23068886 |
| 73 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.23061866 |
| 74 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22494361 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22350062 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21948345 |
| 77 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.21096190 |
| 78 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.19075916 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18868616 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.18832208 |
| 81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.18377410 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18189941 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.16916282 |
| 84 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15761285 |
| 85 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15382345 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14365617 |
| 87 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.11725493 |
| 88 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11204058 |
| 89 | MYB_26560356_Chip-Seq_TH1_Human | 1.10810243 |
| 90 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.10737892 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08144983 |
| 92 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07421372 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07219163 |
| 94 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06867203 |
| 95 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06616394 |
| 96 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05571646 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04974676 |
| 98 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02863768 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01445844 |
| 100 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.01264836 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.01156387 |
| 102 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98901100 |
| 103 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98248580 |
| 104 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96552008 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96502006 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96501698 |
| 107 | P300_19829295_ChIP-Seq_ESCs_Human | 0.96095891 |
| 108 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95795475 |
| 109 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95462986 |
| 110 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.95373503 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95146716 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.94922920 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94770391 |
| 114 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.94066739 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93943092 |
| 116 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93176613 |
| 117 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.93008127 |
| 118 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92620154 |
| 119 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.92198901 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92007477 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90580067 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89563182 |
| 123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88598905 |
| 124 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87420015 |
| 125 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.87089275 |
| 126 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86466293 |
| 127 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.85958370 |
| 128 | MYB_26560356_Chip-Seq_TH2_Human | 0.85142907 |
| 129 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84400721 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83213234 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82530282 |
| 132 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82050597 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.81008260 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80712817 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.79717070 |
| 136 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.79571452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005408_hypopigmentation | 3.36738917 |
| 2 | MP0008057_abnormal_DNA_replication | 3.35498954 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 3.31939746 |
| 4 | MP0000569_abnormal_digit_pigmentation | 3.12961228 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.84360314 |
| 6 | MP0005257_abnormal_intraocular_pressure | 2.64072362 |
| 7 | * MP0000372_irregular_coat_pigmentation | 2.56429210 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.55791683 |
| 9 | MP0010386_abnormal_urinary_bladder | 2.53588376 |
| 10 | MP0005083_abnormal_biliary_tract | 2.37292739 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.28943122 |
| 12 | MP0004381_abnormal_hair_follicle | 2.27111924 |
| 13 | MP0010307_abnormal_tumor_latency | 2.17061451 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.12629346 |
| 15 | MP0002163_abnormal_gland_morphology | 2.09738293 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.07111345 |
| 17 | * MP0000371_diluted_coat_color | 2.03738332 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.03227706 |
| 19 | MP0005367_renal/urinary_system_phenotyp | 1.97396566 |
| 20 | MP0000516_abnormal_urinary_system | 1.97396566 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 1.96508592 |
| 22 | * MP0008438_abnormal_cutaneous_collagen | 1.95150297 |
| 23 | MP0004883_abnormal_blood_vessel | 1.88102039 |
| 24 | * MP0005171_absent_coat_pigmentation | 1.82740486 |
| 25 | MP0002006_tumorigenesis | 1.81079890 |
| 26 | * MP0005275_abnormal_skin_tensile | 1.79511751 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.76862037 |
| 28 | MP0004272_abnormal_basement_membrane | 1.74651589 |
| 29 | MP0004147_increased_porphyrin_level | 1.72901109 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.72644707 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.71345978 |
| 32 | MP0002938_white_spotting | 1.65581119 |
| 33 | MP0000015_abnormal_ear_pigmentation | 1.57327253 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.57059220 |
| 35 | MP0003303_peritoneal_inflammation | 1.55976358 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.53513687 |
| 37 | MP0005164_abnormal_response_to | 1.53203197 |
| 38 | MP0005248_abnormal_Harderian_gland | 1.53080543 |
| 39 | MP0001800_abnormal_humoral_immune | 1.52488813 |
| 40 | MP0004484_altered_response_of | 1.50673573 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.50641895 |
| 42 | MP0002277_abnormal_respiratory_mucosa | 1.48014015 |
| 43 | MP0005076_abnormal_cell_differentiation | 1.47472766 |
| 44 | MP0000685_abnormal_immune_system | 1.46274922 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.39554199 |
| 46 | MP0002419_abnormal_innate_immunity | 1.37224409 |
| 47 | MP0006054_spinal_hemorrhage | 1.35677802 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.35251726 |
| 49 | MP0003828_pulmonary_edema | 1.34684382 |
| 50 | MP0000427_abnormal_hair_cycle | 1.33823849 |
| 51 | MP0003122_maternal_imprinting | 1.31778211 |
| 52 | MP0010678_abnormal_skin_adnexa | 1.29400309 |
| 53 | MP0000538_abnormal_urinary_bladder | 1.27686224 |
| 54 | MP0003436_decreased_susceptibility_to | 1.26863988 |
| 55 | MP0003121_genomic_imprinting | 1.26128812 |
| 56 | MP0003172_abnormal_lysosome_physiology | 1.25221030 |
| 57 | MP0008260_abnormal_autophagy | 1.24279173 |
| 58 | MP0005197_abnormal_uvea_morphology | 1.23526304 |
| 59 | MP0002168_other_aberrant_phenotype | 1.23434909 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22948242 |
| 61 | MP0002009_preneoplasia | 1.21495371 |
| 62 | * MP0001186_pigmentation_phenotype | 1.19754342 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.19406567 |
| 64 | MP0003448_altered_tumor_morphology | 1.18987966 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.18678482 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.18553128 |
| 67 | MP0000733_abnormal_muscle_development | 1.17882892 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.16806515 |
| 69 | MP0001819_abnormal_immune_cell | 1.16485337 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.16095613 |
| 71 | MP0002398_abnormal_bone_marrow | 1.14827716 |
| 72 | MP0005023_abnormal_wound_healing | 1.12890305 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 1.09928867 |
| 74 | MP0006082_CNS_inflammation | 1.09769926 |
| 75 | * MP0002075_abnormal_coat/hair_pigmentati | 1.08553126 |
| 76 | MP0003091_abnormal_cell_migration | 1.08358949 |
| 77 | MP0002396_abnormal_hematopoietic_system | 1.07553786 |
| 78 | MP0000767_abnormal_smooth_muscle | 1.07405221 |
| 79 | MP0003195_calcinosis | 1.06885342 |
| 80 | MP0003890_abnormal_embryonic-extraembry | 1.06599068 |
| 81 | MP0004947_skin_inflammation | 1.04885591 |
| 82 | MP0009785_altered_susceptibility_to | 1.04261737 |
| 83 | MP0002452_abnormal_antigen_presenting | 1.04144930 |
| 84 | MP0001790_abnormal_immune_system | 1.03895221 |
| 85 | MP0005387_immune_system_phenotype | 1.03895221 |
| 86 | MP0009764_decreased_sensitivity_to | 1.03266067 |
| 87 | MP0001958_emphysema | 1.02832468 |
| 88 | MP0000689_abnormal_spleen_morphology | 1.02115186 |
| 89 | MP0005000_abnormal_immune_tolerance | 1.01556174 |
| 90 | MP0005075_abnormal_melanosome_morpholog | 1.00519628 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.99742873 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.98740960 |
| 93 | MP0001324_abnormal_eye_pigmentation | 0.98611855 |
| 94 | MP0000383_abnormal_hair_follicle | 0.98581425 |
| 95 | MP0002722_abnormal_immune_system | 0.98561792 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.98510333 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.97080612 |
| 98 | MP0005671_abnormal_response_to | 0.96821173 |
| 99 | MP0003866_abnormal_defecation | 0.94565994 |
| 100 | MP0002693_abnormal_pancreas_physiology | 0.94024309 |
| 101 | MP0003045_fibrosis | 0.93882139 |
| 102 | MP0001299_abnormal_eye_distance/ | 0.92243482 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.92013909 |
| 104 | MP0000716_abnormal_immune_system | 0.91747643 |
| 105 | MP0003123_paternal_imprinting | 0.89768941 |
| 106 | MP0003453_abnormal_keratinocyte_physiol | 0.89590338 |
| 107 | MP0004264_abnormal_extraembryonic_tissu | 0.89124620 |
| 108 | MP0004134_abnormal_chest_morphology | 0.88169072 |
| 109 | MP0005310_abnormal_salivary_gland | 0.87034507 |
| 110 | MP0002177_abnormal_outer_ear | 0.85736090 |
| 111 | MP0002928_abnormal_bile_duct | 0.83590424 |
| 112 | MP0000858_altered_metastatic_potential | 0.83529671 |
| 113 | * MP0001191_abnormal_skin_condition | 0.83008317 |
| 114 | MP0003385_abnormal_body_wall | 0.82124348 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.81716677 |
| 116 | MP0003724_increased_susceptibility_to | 0.81191191 |
| 117 | * MP0005390_skeleton_phenotype | 0.81186650 |
| 118 | MP0005025_abnormal_response_to | 0.80641681 |
| 119 | MP0000613_abnormal_salivary_gland | 0.80256543 |
| 120 | * MP0002098_abnormal_vibrissa_morphology | 0.79759936 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.79490121 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.79490121 |
| 123 | * MP0001175_abnormal_lung_morphology | 0.79048261 |
| 124 | * MP0005508_abnormal_skeleton_morphology | 0.78877558 |
| 125 | MP0003787_abnormal_imprinting | 0.78485720 |
| 126 | MP0001756_abnormal_urination | 0.78399535 |
| 127 | MP0001915_intracranial_hemorrhage | 0.77953345 |
| 128 | MP0000703_abnormal_thymus_morphology | 0.77724974 |
| 129 | MP0009278_abnormal_bone_marrow | 0.76715312 |
| 130 | MP0002405_respiratory_system_inflammati | 0.76648690 |
| 131 | MP0002723_abnormal_immune_serum | 0.76644298 |
| 132 | MP0009115_abnormal_fat_cell | 0.76254928 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.75369099 |
| 134 | MP0002429_abnormal_blood_cell | 0.75261041 |
| 135 | MP0000432_abnormal_head_morphology | 0.75163865 |
| 136 | MP0005451_abnormal_body_composition | 0.74124065 |
| 137 | MP0002896_abnormal_bone_mineralization | 0.73950480 |
| 138 | MP0002796_impaired_skin_barrier | 0.73718333 |
| 139 | * MP0005503_abnormal_tendon_morphology | 0.73532358 |
| 140 | MP0003795_abnormal_bone_structure | 0.73135042 |
| 141 | MP0008004_abnormal_stomach_pH | 0.72153954 |
| 142 | MP0005409_darkened_coat_color | 0.71314721 |
| 143 | MP0003959_abnormal_lean_body | 0.71222411 |
| 144 | MP0001216_abnormal_epidermal_layer | 0.69312265 |
| 145 | MP0004084_abnormal_cardiac_muscle | 0.68083507 |
| 146 | MP0001784_abnormal_fluid_regulation | 0.67323396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 4.61379919 |
| 2 | Decreased circulating renin level (HP:0003351) | 4.39726699 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 3.79564819 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 3.78069231 |
| 5 | Abnormality of the right ventricle (HP:0001707) | 3.69556043 |
| 6 | Asymmetry of the thorax (HP:0001555) | 3.65013614 |
| 7 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.35275655 |
| 8 | Poikilocytosis (HP:0004447) | 3.29038472 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.22714805 |
| 10 | Cutaneous melanoma (HP:0012056) | 3.14545024 |
| 11 | T lymphocytopenia (HP:0005403) | 3.12284240 |
| 12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.09500222 |
| 13 | Subacute progressive viral hepatitis (HP:0006572) | 2.98113506 |
| 14 | Hyperaldosteronism (HP:0000859) | 2.93702314 |
| 15 | Abnormality of T cell number (HP:0011839) | 2.91308526 |
| 16 | Abnormality of chloride homeostasis (HP:0011422) | 2.89773496 |
| 17 | Curly hair (HP:0002212) | 2.81624500 |
| 18 | Peritonitis (HP:0002586) | 2.81222070 |
| 19 | Recurrent abscess formation (HP:0002722) | 2.77205551 |
| 20 | Macroorchidism (HP:0000053) | 2.74444877 |
| 21 | Hypokalemia (HP:0002900) | 2.72403625 |
| 22 | Hyperkalemia (HP:0002153) | 2.71327841 |
| 23 | Neoplasm of the adrenal cortex (HP:0100641) | 2.68017301 |
| 24 | Dysostosis multiplex (HP:0000943) | 2.63904415 |
| 25 | Spondylolisthesis (HP:0003302) | 2.61114988 |
| 26 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.59565325 |
| 27 | Neoplasm of the heart (HP:0100544) | 2.55727354 |
| 28 | Vacuolated lymphocytes (HP:0001922) | 2.55298168 |
| 29 | Vertebral arch anomaly (HP:0008438) | 2.53490864 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 2.52462798 |
| 31 | Chronic bronchitis (HP:0004469) | 2.47757234 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.44032176 |
| 33 | Recurrent skin infections (HP:0001581) | 2.42267214 |
| 34 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.39537505 |
| 35 | Short 4th metacarpal (HP:0010044) | 2.39537505 |
| 36 | Acanthocytosis (HP:0001927) | 2.38583961 |
| 37 | Abnormality of secondary sexual hair (HP:0009888) | 2.36134228 |
| 38 | Abnormality of the axillary hair (HP:0100134) | 2.36134228 |
| 39 | Deformed sella turcica (HP:0002681) | 2.35496492 |
| 40 | Generalized hypopigmentation of hair (HP:0011358) | 2.34977967 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 2.33213975 |
| 42 | Renal salt wasting (HP:0000127) | 2.32641923 |
| 43 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.32501882 |
| 44 | Polycythemia (HP:0001901) | 2.30126079 |
| 45 | Rectal prolapse (HP:0002035) | 2.28088473 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.26809105 |
| 47 | Increased IgE level (HP:0003212) | 2.26747624 |
| 48 | Hyponatremia (HP:0002902) | 2.26585856 |
| 49 | Thoracolumbar scoliosis (HP:0002944) | 2.25691134 |
| 50 | Viral hepatitis (HP:0006562) | 2.24217397 |
| 51 | Pelvic girdle muscle weakness (HP:0003749) | 2.23830149 |
| 52 | * Spontaneous hematomas (HP:0007420) | 2.20663853 |
| 53 | Truncal obesity (HP:0001956) | 2.18384603 |
| 54 | Hypochromic microcytic anemia (HP:0004840) | 2.18118170 |
| 55 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.18099672 |
| 56 | Hypoplasia of the fovea (HP:0007750) | 2.18099672 |
| 57 | Autoimmune thrombocytopenia (HP:0001973) | 2.17997931 |
| 58 | Microcytic anemia (HP:0001935) | 2.17400613 |
| 59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.16124767 |
| 60 | Albinism (HP:0001022) | 2.15922100 |
| 61 | Osteomalacia (HP:0002749) | 2.15693193 |
| 62 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15110148 |
| 63 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.14374058 |
| 64 | Enlarged penis (HP:0000040) | 2.13104699 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.12480194 |
| 66 | Abnormality of the sella turcica (HP:0002679) | 2.12426764 |
| 67 | Thyroiditis (HP:0100646) | 2.11963582 |
| 68 | Osteolytic defects of the hand bones (HP:0009699) | 2.10740321 |
| 69 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10740321 |
| 70 | Diastasis recti (HP:0001540) | 2.09798318 |
| 71 | Abnormality of potassium homeostasis (HP:0011042) | 2.09464846 |
| 72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09448702 |
| 73 | Mucopolysacchariduria (HP:0008155) | 2.09448702 |
| 74 | Thick nail (HP:0001805) | 2.09326306 |
| 75 | Recurrent viral infections (HP:0004429) | 2.08321334 |
| 76 | Prostate neoplasm (HP:0100787) | 2.08309183 |
| 77 | Cervical subluxation (HP:0003308) | 2.07637637 |
| 78 | Deep philtrum (HP:0002002) | 2.04695584 |
| 79 | Overgrowth (HP:0001548) | 2.04410172 |
| 80 | Narrow palate (HP:0000189) | 2.02270151 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.01403655 |
| 82 | Autoimmune hemolytic anemia (HP:0001890) | 2.00788366 |
| 83 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.99439503 |
| 84 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.99439503 |
| 85 | Lip pit (HP:0100267) | 1.98905411 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 1.98681871 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.98681871 |
| 88 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.98661736 |
| 89 | Gingivitis (HP:0000230) | 1.97275019 |
| 90 | Abnormality of cochlea (HP:0000375) | 1.97181249 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.97095751 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.97095751 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.97095751 |
| 94 | Chest pain (HP:0100749) | 1.95327417 |
| 95 | Gingival bleeding (HP:0000225) | 1.94779447 |
| 96 | Fair hair (HP:0002286) | 1.94648857 |
| 97 | Volvulus (HP:0002580) | 1.93251391 |
| 98 | Retrobulbar optic neuritis (HP:0100654) | 1.90752314 |
| 99 | Optic neuritis (HP:0100653) | 1.90752314 |
| 100 | Aortic aneurysm (HP:0004942) | 1.90685408 |
| 101 | Hypoplastic labia majora (HP:0000059) | 1.90593062 |
| 102 | Papillary thyroid carcinoma (HP:0002895) | 1.89513879 |
| 103 | Abnormality of the nasal septum (HP:0000419) | 1.88855780 |
| 104 | Glomerulonephritis (HP:0000099) | 1.87956751 |
| 105 | Spinal cord lesions (HP:0100561) | 1.87799781 |
| 106 | Syringomyelia (HP:0003396) | 1.87799781 |
| 107 | Striae distensae (HP:0001065) | 1.87340874 |
| 108 | Cerebral aneurysm (HP:0004944) | 1.85771719 |
| 109 | Heterochromia iridis (HP:0001100) | 1.84267664 |
| 110 | Prominent nose (HP:0000448) | 1.84143679 |
| 111 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83834170 |
| 112 | Absent frontal sinuses (HP:0002688) | 1.83827803 |
| 113 | Acute myeloid leukemia (HP:0004808) | 1.83715500 |
| 114 | Large earlobe (HP:0009748) | 1.82529431 |
| 115 | Abnormality of the fovea (HP:0000493) | 1.82066198 |
| 116 | Thyroid carcinoma (HP:0002890) | 1.81390970 |
| 117 | Termporal pattern (HP:0011008) | 1.81165719 |
| 118 | Insidious onset (HP:0003587) | 1.81165719 |
| 119 | Broad face (HP:0000283) | 1.81140620 |
| 120 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.81045691 |
| 121 | Leukocytosis (HP:0001974) | 1.80006351 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.79806321 |
| 123 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.79806321 |
| 124 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.79806321 |
| 125 | Abnormality of the frontal sinuses (HP:0002687) | 1.79693037 |
| 126 | Abnormality of renin-angiotensin system (HP:0000847) | 1.78754113 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.78705833 |
| 128 | Recurrent bronchitis (HP:0002837) | 1.78443096 |
| 129 | Aortic dissection (HP:0002647) | 1.78214146 |
| 130 | Dilatation of the ascending aorta (HP:0005111) | 1.76933233 |
| 131 | Abnormality of macrophages (HP:0004311) | 1.76567148 |
| 132 | Keratoconjunctivitis (HP:0001096) | 1.76051204 |
| 133 | Submucous cleft hard palate (HP:0000176) | 1.75585332 |
| 134 | * Bladder neoplasm (HP:0009725) | 1.75488376 |
| 135 | * Bladder carcinoma (HP:0002862) | 1.75488376 |
| 136 | Hypoglycemic seizures (HP:0002173) | 1.74954499 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74295855 |
| 138 | Metabolic alkalosis (HP:0200114) | 1.73679372 |
| 139 | IgA deficiency (HP:0002720) | 1.72633680 |
| 140 | Craniofacial hyperostosis (HP:0004493) | 1.72461046 |
| 141 | Hip dysplasia (HP:0001385) | 1.70488746 |
| 142 | Micronodular cirrhosis (HP:0001413) | 1.69717310 |
| 143 | Generalized hypopigmentation (HP:0007513) | 1.69399060 |
| 144 | Abnormality of the labia majora (HP:0012881) | 1.69086140 |
| 145 | * Osteomyelitis (HP:0002754) | 1.68473726 |
| 146 | Intestinal fistula (HP:0100819) | 1.67803193 |
| 147 | Lower limb hyperreflexia (HP:0002395) | 1.67798448 |
| 148 | Arterial thrombosis (HP:0004420) | 1.67644655 |
| 149 | Blue irides (HP:0000635) | 1.67047167 |
| 150 | Basal ganglia calcification (HP:0002135) | 1.66421374 |
| 151 | Esophageal varix (HP:0002040) | 1.66116320 |
| 152 | Myositis (HP:0100614) | 1.65947774 |
| 153 | Abnormality of T cells (HP:0002843) | 1.65884766 |
| 154 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.65736364 |
| 155 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.65256198 |
| 156 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65151024 |
| 157 | Abnormality of sodium homeostasis (HP:0010931) | 1.65023044 |
| 158 | Aqueductal stenosis (HP:0002410) | 1.64790224 |
| 159 | Hypoplasia of the iris (HP:0007676) | 1.64745533 |
| 160 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.64481675 |
| 161 | Uterine leiomyosarcoma (HP:0002891) | 1.63731974 |
| 162 | Leiomyosarcoma (HP:0100243) | 1.63731974 |
| 163 | Periodontitis (HP:0000704) | 1.63424030 |
| 164 | Premature rupture of membranes (HP:0001788) | 1.63279239 |
| 165 | Sandal gap (HP:0001852) | 1.62893524 |
| 166 | Thickened calvaria (HP:0002684) | 1.62880232 |
| 167 | Abnormality of the lumbar spine (HP:0100712) | 1.62427502 |
| 168 | Low anterior hairline (HP:0000294) | 1.62347865 |
| 169 | Orchitis (HP:0100796) | 1.61739952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.34460090 |
| 2 | LATS1 | 3.30986387 |
| 3 | FGFR2 | 2.82193920 |
| 4 | LMTK2 | 2.67581627 |
| 5 | NUAK1 | 2.59263023 |
| 6 | INSRR | 2.56038891 |
| 7 | EPHA3 | 2.32036181 |
| 8 | FGFR3 | 2.05222688 |
| 9 | PIK3CG | 1.96307431 |
| 10 | MST1R | 1.94602167 |
| 11 | MAP3K14 | 1.80151852 |
| 12 | TGFBR2 | 1.79621720 |
| 13 | RIPK4 | 1.79522822 |
| 14 | CLK1 | 1.78354383 |
| 15 | STK3 | 1.77384060 |
| 16 | BRD4 | 1.67007422 |
| 17 | CDK12 | 1.64978548 |
| 18 | ERBB3 | 1.63052145 |
| 19 | CHUK | 1.57198274 |
| 20 | EIF2AK1 | 1.57116272 |
| 21 | MET | 1.54727692 |
| 22 | CAMK1D | 1.53091598 |
| 23 | PTK6 | 1.51195720 |
| 24 | JAK2 | 1.47125868 |
| 25 | TAOK3 | 1.43738999 |
| 26 | MAP2K3 | 1.41436170 |
| 27 | MARK3 | 1.37057327 |
| 28 | SCYL2 | 1.36527523 |
| 29 | TYK2 | 1.34854879 |
| 30 | ZAK | 1.28444462 |
| 31 | TBK1 | 1.26578287 |
| 32 | SGK2 | 1.26485161 |
| 33 | NEK9 | 1.26118280 |
| 34 | FLT3 | 1.19846862 |
| 35 | KIT | 1.19582197 |
| 36 | STK10 | 1.16976956 |
| 37 | PDGFRA | 1.16624355 |
| 38 | RET | 1.16275275 |
| 39 | PTK2B | 1.15419913 |
| 40 | BTK | 1.15180830 |
| 41 | IKBKB | 1.13148990 |
| 42 | MAP3K2 | 1.12065849 |
| 43 | KSR1 | 1.12046090 |
| 44 | CCNB1 | 1.11490305 |
| 45 | PASK | 1.08808006 |
| 46 | MAP3K6 | 1.08356796 |
| 47 | JAK1 | 1.07135444 |
| 48 | MAP2K4 | 1.04954524 |
| 49 | MAP3K3 | 1.03503241 |
| 50 | JAK3 | 1.01789978 |
| 51 | KSR2 | 1.01775558 |
| 52 | MAPK15 | 1.01468299 |
| 53 | IRAK4 | 1.01100762 |
| 54 | SYK | 0.96911025 |
| 55 | CAMK1G | 0.95944961 |
| 56 | ERN1 | 0.94773216 |
| 57 | MAP3K4 | 0.94048570 |
| 58 | ACVR1B | 0.93225229 |
| 59 | CAMK4 | 0.93098194 |
| 60 | BMPR1B | 0.89399284 |
| 61 | CAMKK2 | 0.88453240 |
| 62 | STK38L | 0.87866916 |
| 63 | ITK | 0.85652169 |
| 64 | SGK3 | 0.84925467 |
| 65 | IKBKE | 0.83509783 |
| 66 | MAP3K1 | 0.83415719 |
| 67 | BRSK2 | 0.82915902 |
| 68 | TTN | 0.82537456 |
| 69 | IRAK3 | 0.82497717 |
| 70 | FER | 0.81385147 |
| 71 | TRPM7 | 0.81294490 |
| 72 | GRK6 | 0.81213399 |
| 73 | PRKAA2 | 0.80788852 |
| 74 | MAP4K1 | 0.80574618 |
| 75 | BMPR2 | 0.79769790 |
| 76 | PDGFRB | 0.78299897 |
| 77 | CSF1R | 0.76043670 |
| 78 | BMX | 0.75857643 |
| 79 | RAF1 | 0.75331006 |
| 80 | STK24 | 0.74884643 |
| 81 | EPHB1 | 0.74869625 |
| 82 | MELK | 0.73653248 |
| 83 | EIF2AK2 | 0.72097196 |
| 84 | STK4 | 0.69987646 |
| 85 | MAPK7 | 0.69967611 |
| 86 | CDK6 | 0.69380889 |
| 87 | DMPK | 0.68710538 |
| 88 | MAP3K10 | 0.68531527 |
| 89 | PLK3 | 0.68015802 |
| 90 | RPS6KA4 | 0.68014060 |
| 91 | YES1 | 0.67645714 |
| 92 | EEF2K | 0.67386849 |
| 93 | GRK7 | 0.67309568 |
| 94 | TGFBR1 | 0.67308337 |
| 95 | MTOR | 0.65713902 |
| 96 | ADRBK2 | 0.65390470 |
| 97 | RPS6KA5 | 0.64392109 |
| 98 | HIPK2 | 0.63528451 |
| 99 | DDR2 | 0.62779766 |
| 100 | PBK | 0.62722829 |
| 101 | MAP2K1 | 0.62051832 |
| 102 | EIF2AK3 | 0.61564003 |
| 103 | MAP3K7 | 0.61216970 |
| 104 | MAPK12 | 0.58887283 |
| 105 | PIM1 | 0.57920153 |
| 106 | MAP3K5 | 0.57572577 |
| 107 | BCR | 0.57564486 |
| 108 | TEC | 0.57031125 |
| 109 | AKT3 | 0.55610792 |
| 110 | MAPK13 | 0.54490791 |
| 111 | PRKCE | 0.54450173 |
| 112 | PRKAA1 | 0.54034706 |
| 113 | CSK | 0.52982325 |
| 114 | PAK3 | 0.52671841 |
| 115 | PLK2 | 0.51272577 |
| 116 | MATK | 0.51185035 |
| 117 | INSR | 0.50852893 |
| 118 | IRAK2 | 0.48660133 |
| 119 | IGF1R | 0.48519425 |
| 120 | DYRK3 | 0.48322016 |
| 121 | BLK | 0.48310209 |
| 122 | FGR | 0.47875216 |
| 123 | SRPK1 | 0.47515408 |
| 124 | PRKG2 | 0.46760066 |
| 125 | CDK9 | 0.45998659 |
| 126 | LCK | 0.45204645 |
| 127 | GSK3A | 0.45172873 |
| 128 | WNK1 | 0.44297287 |
| 129 | ATM | 0.44119643 |
| 130 | NLK | 0.43795424 |
| 131 | PRPF4B | 0.43678503 |
| 132 | PKN2 | 0.42802091 |
| 133 | PRKD3 | 0.42705697 |
| 134 | ERBB2 | 0.42506906 |
| 135 | LYN | 0.41570374 |
| 136 | SGK1 | 0.39772146 |
| 137 | ADRBK1 | 0.39438721 |
| 138 | TXK | 0.38843637 |
| 139 | HCK | 0.37282117 |
| 140 | MST4 | 0.37175558 |
| 141 | PRKCH | 0.36388242 |
| 142 | ATR | 0.35789002 |
| 143 | MAPKAPK2 | 0.33969178 |
| 144 | FGFR4 | 0.33507754 |
| 145 | IRAK1 | 0.33401318 |
| 146 | ZAP70 | 0.33372536 |
| 147 | EGFR | 0.33134216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 2.03675690 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.96596670 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94776266 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.91596653 |
| 5 | Adherens junction_Homo sapiens_hsa04520 | 1.88439479 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.82739683 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.78448644 |
| 8 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.75559143 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.75470073 |
| 10 | Legionellosis_Homo sapiens_hsa05134 | 1.75112347 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.71687810 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.58703927 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.50414405 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50283581 |
| 15 | Alcoholism_Homo sapiens_hsa05034 | 1.48722573 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.48265319 |
| 17 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.42444296 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41149158 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.40866605 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38988432 |
| 21 | Protein export_Homo sapiens_hsa03060 | 1.38886403 |
| 22 | Prostate cancer_Homo sapiens_hsa05215 | 1.37228266 |
| 23 | Phagosome_Homo sapiens_hsa04145 | 1.35454256 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.33444603 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32860930 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.32690253 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.30721424 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.30189057 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.30123766 |
| 30 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29813619 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25818865 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.25815716 |
| 33 | Allograft rejection_Homo sapiens_hsa05330 | 1.25603452 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25525002 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24936835 |
| 36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.23474869 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.18597491 |
| 38 | Focal adhesion_Homo sapiens_hsa04510 | 1.17981406 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16710027 |
| 40 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14449048 |
| 41 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.14125485 |
| 42 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13934908 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.10192149 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10062218 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09844312 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09452384 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.09428687 |
| 48 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09119483 |
| 49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.09029425 |
| 50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07552460 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06589654 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04908780 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.04481063 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04058034 |
| 55 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.03804389 |
| 56 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01906431 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01602976 |
| 58 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01292577 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00848494 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00208606 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99983552 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98697776 |
| 63 | Glioma_Homo sapiens_hsa05214 | 0.97219328 |
| 64 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.96123542 |
| 65 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94847239 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.91503911 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90386517 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.90171623 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.89206487 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87585052 |
| 71 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86779340 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86414774 |
| 73 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.85697850 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.85122244 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84695404 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84461005 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.83943218 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83724589 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83491164 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82326471 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.82149901 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.79276491 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.78560758 |
| 84 | * Mineral absorption_Homo sapiens_hsa04978 | 0.78449289 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.75701505 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75670114 |
| 87 | Hepatitis C_Homo sapiens_hsa05160 | 0.73127992 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.72910609 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71375636 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.70841000 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69742353 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69575415 |
| 93 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.69282149 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68467031 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.68362366 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68145890 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67677546 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.67532468 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.67442448 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66783574 |
| 101 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66765203 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.65254951 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64591208 |
| 104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.64500164 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.64088167 |
| 106 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64053743 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.62173284 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62055081 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61943200 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60414539 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60388024 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.59284264 |
| 113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59113362 |
| 114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57439786 |
| 115 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57130154 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56867488 |
| 117 | Thyroid cancer_Homo sapiens_hsa05216 | 0.56226314 |
| 118 | Asthma_Homo sapiens_hsa05310 | 0.55883255 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.55704394 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55376084 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.54227338 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53039981 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53031665 |
| 124 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.52929859 |
| 125 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52782388 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52596213 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52462239 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51708694 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48700024 |
| 130 | Long-term depression_Homo sapiens_hsa04730 | 0.48540298 |

